• Automotive industry faces massive disruption led by adoption of emission reduction mandates, software-centric driving systems, and ADAS/AV technology
• Entering execution phase of higher levels of ADAS and AV technology with several OEMs preparing to build fully or near-fully autonomous vehicles ready for public roads
• Lidar complements camera-based perception technology by “seeing” things in 3D rather than 2D
• Cepton is taking lidar mainstream by engaging with leading global automotive OEMs to cost-effectively deploy lidar at scale

The automotive industry has faced massive disruption in the last few years, led primarily by the adoption of emission reduction mandates, software-centric driving systems, and autonomous vehicle (“AV”) and advanced driver assistance system (“ADAS”) technology. As a result, OEMs have redefined their business models to incorporate new products, adapt to growing vehicle safety concerns, and address increased consumer demand for a superior driving experience. Following decades of research and development, the industry is finally entering the execution phase of higher levels of ADAS and AV technology as OEMs prepare to build fully or near-fully autonomous vehicles ready for public roads. Cepton (NASDAQ: CPTN), a Silicon Valley innovator of lidar-based solutions for the automotive (“ADAS/AV”) and smart technology spaces, leads the way in enabling the world’s leading automotive companies to integrate lidar at scale and transition to an increasingly adaptive, safety-centric future. Safety is at the forefront of ADAS/AV technology concerns, and the industry’s success hinges on the availability of perception solutions that accurately identify objects under various conditions. Dr. Jun Pei, CEO and Co-Founder of Cepton, recently addressed the issue in an article that focuses on safety hazards brought about by alleged “smart” features and how lidar has many capabilities that are superior to camera-based perception solutions (https://ibn.fm/BdRt9). “A few companies – the most popular being Tesla – have invested their future advancements in camera-based computer vision to address common driving scenarios and enhance safety,” reads the article. “As a lidar company CEO it is no surprise that I am constantly asked to comment on Musk’s view on lidar. Instead of treating it as an attack, I see it as an opportunity to clear up the common misconceptions around lidar technology.” Dr. Pei believes lidar brings unparalleled vehicle perception by “seeing” things in 3D instead of the standard 2D view produced by cameras. By being able to perceive depth, lidar provides additional information critical to maintaining vehicle safety and protecting pedestrians, structures, and other objects within the vehicle’s surroundings. “Let’s say there is a dog in the street. A camera will capture the dog’s color, but it can’t tell you if it’s a small dog right in front of you, or a big dog 30 ft. away,” continues Dr. Pei in the article. “Lidar will tell you how big this dog is, how far away it is and how fast it is running. It can even tell you if the dog is accelerating or slowing down. This 3D imaging capability is key to real-time vehicle perception.” Cepton is taking lidar mainstream by engaging with leading global automotive OEMs such as Ford Motor Company to make it a standard safety feature in all vehicles. According to a 2021 article by Ford, CPTN engaged with the company over several years for research, development, and small-scale deployments (https://ibn.fm/cPvFO). In addition to delivering custom lidar solutions for R&D on advanced ADAS features, Cepton also helped Ford deploy lidar solutions on select smart city projects. Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California with a presence in Germany, Canada, Japan, India, and China, and has recently opened a Center of Excellence in Detroit. With a dedicated team of researchers and scientists, Cepton aims to make its patented technology mainstream to deploy scalable and intelligent 3D perception solutions that enable an adaptive, safety-centric future. For more information, visit the company’s website at www.Cepton.com. NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

Industries, innovators, public and private investment firms, government agencies, utilities, banks, non-profits, and other industry leaders of Southern California, are invited to attend the 13th Annual Energy Event being held on November 2, 2022. The focus of the conference will be a discussion on the forces that drive energy transitions and the trends that follow. Innovation and transition in energy are trending topics due to the recent funding, legislation, policy, ESG initiatives, and investor and consumer demand. Important topics of discussion are electrification, hydrogen, renewables, the built environment, agriculture, grant incentives, investor trends, ESG, innovation, and, most importantly, the Inflation Reduction Act, which a report in The Atlantic suggests will be far bigger than expected, shaping the direction of the American economy https://ibn.fm/AEgb8. Functioning for over twelve years, this SoCal witnesses leading industries and businesses who gather on this forum to nurture networking and collaborations. These interactive sessions are key to economic growth where thought leaders arrive at important solutions for Southern California’s evolving energy needs and sustainability issues. Sustain SoCal, formerly known as Cleantech OC and Sustain OC, has long been associated with researching, analyzing, and implementing practical, sustainable solutions for the basic amenities issues in Southern California. They also offer viable solutions for the challenges in areas of energy, water, and transportation created by the growth, change, and discrepancy issues that face Southern California. Sustain SoCal is a non-profit trade association based in Irvine, California. The organization facilitates innovation, collaboration and education toward sustainability goals and cleantech economic growth through its internal working groups and public conferences and networking events. Sustain SoCal works with corporations, municipal/regional / state / national government agencies, schools, hospitals, nonprofits, investors, and other energy, transportation and water stakeholders in the region to strengthen the core issues in the sector. The event closes with an innovator showcase and networking session after the conference (5 PM – 7 PM). The welcome is done by the SoCal Board of Directors, followed by a keynote speech, panel discussions, and case studies. To learn more, please visit https://ibn.fm/6h7tg.

• California governor signs 10 cannabis-related bills into law
• Bills intended to “strengthen California’s cannabis laws, expand the legal cannabis market and redress the harms of cannabis prohibition”
• ACTX’s Grow Pods offer unmatched control, are capturing a great deal of attention in the cannabis and hemp space

As California Gavin Newsom signed 10 cannabis-related legislative bills into law — all in one day (https://ibn.fm/ge2Kv) — companies operating in the cannabis space, including Advanced Container Technologies (OTC: ACTX), look forward to the impact this government support may have on their success. The governor signed bills designed to expand the legal cannabis market and address impacts from past prohibition of cannabis. He also called on legislators and other policy makers to redouble efforts to tackle barriers to access (https://ibn.fm/LnTNZ). “For too many Californians, the promise of cannabis legalization remains out of reach,” said Newsom. “These measures build on the important strides our state has made toward this goal, but much work remains to build an equitable, safe and sustainable legal cannabis industry. I look forward to partnering with the legislature and policymakers to fully realize cannabis legalization in communities across California.” On Sept. 18, 2022, the governor signed almost a dozen cannabis-related legislative bills into law “in one fell swoop.” The bills touch on issues that run the gamut of the cannabis industry and are intended to “strengthen California’s cannabis laws, expand the legal cannabis market and redress the harms of cannabis prohibition.” The most widely recognized bill of the group, Senate Bill 1326 gives the governor the power to sign cannabis trade agreements with other states that have legalized cannabis. “Other bills address employment protection, labelling, use of cannabis in veterinary medicine and taxation.” The full list of bills Newsom signed include the following:

• AB 1706
• AB 1646
• AB 1885
• AB 1894
• AB 2210
• AB 2188
• AB 2568
• AB 2925
• SB 1186
• SB 1326

This show of government support is almost certain to bolster the efforts of companies operating in all aspects of the cannabis sector. Advanced Containers Technologies is one of those companies. The company is the exclusive U.S. distributor for Grow Pods, which are advanced, self-contained hydroponic containers that are essentially microfarms. These containers feature a controlled, specially filtered environment that allows crops to be grown year-round with a smaller footprint, because the pods use less water and power than more traditional growing systems. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, making the pods ideal for all crops. However, they are capturing a great deal of attention in the cannabis and hemp space. With strict growing, harvesting and packaging regulations in place throughout the cannabis industry, ACTX offers a controlled environment that allows for compliance in all aspects. ACT is in the business of developing, manufacturing and selling advanced cultivation equipment, proprietary packaging systems, and a variety of other products to help businesses and entrepreneurs enter or expand in the rapidly growing cannabis and hemp markets. The company has a keen focus on compliance and provides the expertise, technology and products that allows operators to grow their businesses and their brands quickly, affordably and with a rapid ROI. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com. NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://ibn.fm/ACTX

Join leading cannabis investors, processors, manufacturers, growers, brands, budtenders, retailers, educators, advocates, regulators and more at the Lift&Co. Vancouver Expo, 2023, being held from January 12-14, 2023, at the Vancouver Convention Centre. As Canada’s number-one cannabis conference and trade show, the event will bring unique and innovative ideas and elements as part of an immersive experience that keeps the audience engaged over the course of three days. Day one begins with the Lift Cannabis Business Conference, a business-oriented strategy-focused conference focused on the growth and development of the Canadian cannabis community. Industry stalwarts and fresh voices from the cannabis arena will discourse on important topics, including The ‘Team Canada’ Approach, Advocacy & Lobbying, Cannabis Blockchain, Raising Capital, Indigenous Cannabis, and Speed Breeding, as part of a leading-edge agenda. Businesses and brands from across the cannabis industry then have the opportunity to showcase their products and innovations at the Lift&Co. Expo, open on days two and three of the event. The cannabis community can meet and interact with exhibitors to exchange ideas and build long-lasting relationships. The high-intensity networking and interactive sessions throughout the two “expo days” of the Lift&Co. Expo are not to be missed. In addition, new elements featuring at the expo include a Brand Discovery Pavilion and Cannabis Retailer Zone, as well as a brand-new Budtender Program, designed to honor the unsung heroes of the cannabis industry with free entry and a dedicated lounge, among other perks. Capping off the event, an after-party for attendees to enjoy, mingle and develop new bonds will take place on the evening of Saturday, January 14, 2023. To learn more, please visit https://ibn.fm/S6bbR

• GeoSolar leads decarbonization movement by providing energy-efficient whole-building wsystems that run entirely on renewable energy sources
• GeoSolar’s SmartGreen(TM) Home system comprises solar panels, geothermal ground loops, LED lighting, upgraded insulation, energy-efficient windows
• Company conducting Regulation A+ capital raise with minimum $300 investment

Renewable energy systems that tap into solar and geothermal power have dramatically lowered or eliminated utility bills for some homeowners in Colorado (https://ibn.fm/723Ic). That is in stark contrast to skyrocketing utility bills that threaten the quality of life for families in Europe and the United States while completely destabilizing the global political system. The main difference lies in an ideology that seeks to work with the Earth rather than against it – a core tenet in the philosophy of GeoSolar Technologies (“GST”). By leveraging the power of the sun and earth, GeoSolar aims to lead the decarbonization movement with SmartGreen(TM) whole-building systems that run entirely on renewable energy sources. GeoSolar’s SmartGreen(TM) Home systems provide carbon-free, sustainable energy through solar panels and geothermal ground loops to heat and cool the building, charge electric vehicles, and run appliances. Additional features include upgraded LED lighting, insulation, and windows, and a comprehensive process to tighten the building envelope to save energy and improve efficiency. With options for both existing buildings and new construction, SmartGreen(TM) dramatically lowers utility bills, protects building owners from price shocks, increases property values, improves air quality, and reduces carbon production associated with climate change. Addressing climate change is on the agenda of global governments and corporations throughout the world. According to the United Nations, the Earth is approximately 1.1°C warmer than it was in the late 1800s (https://ibn.fm/K4U1l). To keep it from rising to 1.5°C, the organization states that emissions must reach “Net Zero” by 2050 – a goal GeoSolar is dedicated to achieving. GeoSolar appears to be ahead of its time on multiple fronts. After decades of use in powering energy plants, the United States government finally recognized the viability of geothermal ground loops for residential buildings (https://ibn.fm/1pitE). As a result, supporters in Congress included geothermal energy in the bipartisan infrastructure package passed in 2021, allocating $84 million to demonstration projects and hundreds of billions of dollars in tax incentives and research funding. GeoSolar is positioned to leverage the evolving renewable energy landscape taking shape across the country. With the goal of marketing the green technology to 120 million US homes, the company commenced a Regulation A+ offering that allows investors to participate with a minimum $300 investment. For more information on GeoSolar’s Regulation A+ offering, please visit https://www.manhattanstreetcapital.com/geosolar-technologies-inc. For more information, visit the company’s website at www.GeoSolarPlus.com. NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

• Lexaria Bioscience is a global innovator in drug delivery platforms that has developed the patented DehydraTECH(TM) technology for improved delivery of bioactive compounds
• The company is currently evaluating DehydraTECH-processed CBD as a potential treatment for high blood pressure
• Long-term studies have shown that high blood pressure can increase the risk of developing dementia in later life
• Experts, however, believe that hypertension medication could slow the pace of the cognitive decline
• In addition to helping hypertension patients keep their condition under control, Lexaria’s DehydraTECH-CBD, which has so far been shown to be safe and well tolerated, could potentially help reduce the risk of dementia

Blood pressure or BP typically refers to the pressure exerted by circulating blood against the walls of blood vessels, particularly large arteries and veins. This pressure fluctuates throughout the day depending on the activity in which one engages. However, in some instances, it can consistently cross the normal threshold, a condition known as high blood pressure or hypertension. Usually, and based on a 2017 guideline, a person is said to have high BP when the top reading on the blood pressure monitor, which represents the systolic blood pressure, is greater than 130 mmHg while the bottom reading, which denotes the diastolic pressure, is above 80 mmHg (https://ibn.fm/b9JpP). The constant exertion of elevated pressure on blood vessels damages them by making them less elastic. According to the Centers for Disease Control (“CDC”), this decreases the flow of blood and oxygen to the heart and other body organs. And it is this depressed blood flow that causes progressive damage to organs such as the brain. Long-term research studies have, in fact, shown that high blood pressure among people who are around 40 to 64 years old can increase the risk of developing dementia in later life (https://ibn.fm/gFrnt). One such study, which probed the relationship between high blood pressure and later-life cognition and was published recently in the Journal of Alzheimer’s Disease, found that “people with high blood pressure levels face faster erosion of their ability to think, make decisions, and remember information than those with normal blood pressure levels” (https://ibn.fm/9iazB). And although the study’s findings suggest that hypertension causes faster cognitive decline, they fortunately also indicate that taking antihypertensive drugs could slow the pace of that decline, according to the study’s lead author Deborah Levine, M.D., M.P.H, the director of the Cognitive Health Services Research Program at the University of Michigan. But while hypertension medication is linked to such benefits, patients often shun them, citing their adverse side effects. The resulting suboptimal adherence to existing drugs has given rise to a worrying statistic – according to the CDC, only about 24% of adults with hypertension have it under control, yet the condition causes over 670,000 deaths every year in the United States alone (https://ibn.fm/6DfFl). However, one company, a publicly traded global innovator in drug delivery technology known as Lexaria Bioscience (NASDAQ: LEXX), is out to improve medication adherence and subsequently help prevent the cognitive decline linked to high blood pressure. For Lexaria and the hypertension patients it is targeting, the solution, which is still under development and evaluation, lies in DehydraTECH(TM)-processed cannabidiol (“CBD”). In isolation, CBD has exhibited vasodilatory and antioxidant properties in humans and animals (https://ibn.fm/tEpkA). Its positive effects on blood pressure have also been documented in various research articles, with one such study, which sampled 26 healthy males who were given 600 mg of CBD or placebo orally for seven days, finding that CBD reduces blood pressure at rest after a single dose, although the effect is lost after seven days of treatment. Still, the study showed that CBD resulted in prolonged BP reduction during stressful situations (https://ibn.fm/40Qno). These positive results notwithstanding, CBD is known to have a low oral bioavailability – the proportion of the ingested drug that enters the circulation. According to various reports, the oral bioavailability of CBD stands at approximately 6% (https://ibn.fm/NUUjt), suggesting that users could potentially extract greater BP-related benefits.  For Lexaria, which had developed and patented the DehydraTECH technology that enhances the bioavailability and bioabsorption of various lipophilic active pharmaceutical ingredients (“APIs”), this represented an opportunity that the company then exploited by processing CBD with DehydraTECH. In a 2018 study, Lexaria observed that DehydraTECH delivered 317% more CBD to the blood than controls. And since then, the company has undertaken multiple human clinical studies. In three of the four studies, Lexaria has evidenced that DehydraTECH-CBD results in a rapid and sustained drop in BP, causes a 23% average reduction in overnight blood pressure and reduced arterial stiffness, and triggers attenuated pulmonary artery systolic pressure (https://ibn.fm/WHdod). Results are pending from Lexaria’s largest ever human clinical trial, where dosing completed in July. Backed by the positive findings, Lexaria sought and held a pre-Investigational New Drug (“IND”) meeting with the U.S. FDA, whereupon it received positive feedback and confirmation that supports an abbreviated regulatory pathway in line with section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act (“FD&C Act”). Currently, the company is undertaking requisite processes that are expected to culminate in the filing of an IND application later this year or early next year (https://ibn.fm/7XlMN). Upon submitting the IND filing and receiving a response from the FDA, Lexaria will have the green light to proceed with registered clinical trials. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Fossil fuel sources have transformed the march of human history, yet have also led to a growing measure of pollutants
• As pollution has generated global concerns about the affects of greenhouse gases on climate change, and corresponding effects on humanity, governments and their citizenries have increasingly sought greener solutions for energy consumption
• Clean energy solutions innovator Correlate Infrastructure Partners Inc. is focused on helping to drive climate-friendly adjustments through the analysis of commercial buildings’ energy use and providing clients with surprisingly cost-effective solutions for energy optimization, allowing superior return on investment

Fossil fuels have dominated the energy supply chain for centuries. The transition from biomass energy production from burning wood to energy-dense stored-fuel sources such as coal and then oil, industrial productivity jumped along with population growth. “The world today is unrecognizable from that of the early 19th century, before fossil fuels came into wide use,” Brookings Institution energy researcher Samantha Gross wrote in a report for the Washington, D.C.-based nonprofit public policy organization (https://ibn.fm/eMQLQ). “The fossil fuel energy system is the lifeblood of the modern economy. Fossil fuels powered the industrial revolution, pulled millions out of poverty, and shaped the modern world.” But the transition carried a hidden cost, gradually increasing air-carried pollutants, particularly as the world’s population has grown from 1 billion in 1800 to nearly 8 billion today (https://ibn.fm/3z8TB). In recent years, world governments, industries, and consumers, have increasingly acknowledged the detrimental effects of these fossil fuel generated pollutants on the planet’s climate and have sought out greener remedies. Correlate Infrastructure Partners (OTCQB: CIPI), a growing clean energy solutions innovator, is focused on helping the commercial real estate industry (companies that develop and rent out commercial building properties) to achieve optimal energy use, without prohibitive up-front costs, while leading to a positive return on investment. Although reforms that reduce fossil fuel sources for generating electricity and transportation energy have historically met with adoption resistance because of fossil fuels’ convenience and established infrastructure, Correlate is optimistic that economic and socio-political trends clearly represent an increasing movement toward renewable energy sources that will define future technologies and use standards. The 501(c)3 energy reform nonprofit Rocky Mountain Institute (“RMI”) released its “Energy Transition Narrative” report this year (https://ibn.fm/ps9V7), defining the potential for overcoming historical fossil fuel preferences through data showing the urgency of stemming accelerating changes to the world’s climate, opportunities created as a result of Russia’s war with Ukraine, the economic and human welfare benefits of increased renewables adoption, and evidence that those benefits are already resulting in the motivation to make change despite reluctance on the part of “incumbent” energy producers. Whatever the fuel source being promoted, our energy comes from the sun one way or another, as the Brookings report noted. “Renewables are, obviously, available everywhere,” the 2022 RMI report added. “Even if you massively constrain deployment, the world has annual renewable flows of over 100 times fossil fuel supply.” Drawing on data from the non-profit Carbon Tracker think tank, RMI’s report notes that the planet’s southern hemisphere is “super-abundant” in solar and wind energy potential as a multiple of energy demand, with more than 100 times the expected demand available in South America and Australia and more than 1,000 times available in most of Africa. “Solar rooftops alone could supply us with all our electricity needs,” the report states. “A new cluster of technologies can replace the entire fossil fuel system. … We have all the technologies we need (and) … we know roughly what to do.” For more information, visit Correlate Infrastructure Partners’ website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• The global cannabis market is expected to reach $27.7 billion in 2022, growing at a CAGR of 24.3% through 2027, resulting in an anticipated value of $82.3 billion during the
• forecast period
• REZYFi is positioned as one of the first cannabis mortgage bankers in the United States, using its experience, independent network of brokers, and proprietary technology, to expand alternative financing options in the industry
• The company is currently licensed in 36 states with plans to expand in the future

California began paving the way for cannabis-related businesses in 1996 when voters passed the Compassionate Use Act, legalizing the medicinal use of cannabis. Today, the state has legalized medicinal and recreational use and offers resources for businesses looking to gain traction in the industry. The California cannabis industry is highly regulated to ensure businesses operate safely, provide contaminant-free products, inform purchasers, and keep cannabis away from children. The state has established statutes, regulations, and ordinances that work together to build and protect the cannabis industry for businesses and consumers. Although cannabis is becoming accepted at the state level, there are still hurdles the industry must overcome due to federal regulations – primarily in the traditional banking industry. To succeed, businesses require the use of financial institutions to pay for expenses, save money, manage risk, finance operations, and more, financing which can be difficult for cannabis-related businesses to obtain. The cannabis market is expected to reach a global value of $27.7 billion in 2022. By 2027, research indicates that this value could grow to $82.3 billion at a CAGR of 24.3% (https://ibn.fm/lSklo). The market’s growth is attributed to legalization, with cannabis-related tourism expected to drive the trends of cannabis-related product offerings and destinations offering mass appeal to Gen Z consumers. REZYFi, a growth mortgage origination and specialized financing company, is positioned as one of the first cannabis mortgage bankers in the US, an area most traditional lenders are reticent to serve. The company operates through two wholly-owned subsidiaries – REZYFi Lending and ResMac Inc. – offering solutions for emerging real estate-related financing opportunities and traditional mortgage origination, correspondent, and servicing. The company is using its corporate strengths as pillars for success: Experience – a seasoned management team leads REZYFi with expertise spanning a wide range of real estate and financing subsectors. The team members also have extensive experience in the cannabis and hemp marketplace, which they intend to leverage as it navigates the changing landscape of the cannabis industry while sourcing the best opportunities. Independent Broker Network – REZYFi has created an extensive network of independent mortgage-related brokers and licensed loan officers over the past five years. The company believes this network will be vital as they move forward in the mortgage and cannabis-related sectors. The company is working on training network members on its new service offerings, with many of them already launching sales efforts. Proprietary Technology – REZYFi has invested heavily in designing, building, and implementing proprietary automated/machine learning technology that helps shorten loan processing timeframes and increase efficiency. This allows REZYFi to operate its legacy business at staffing levels below that of its competition. REZYFi is currently licensed in 36 states, with plans to extend coverage to the remaining states in the future. For more information, visit the company’s website at www.REZYFi.com. NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://ibn.fm/REZY

• CubCrafters is an aircraft design and manufacturing company focused on supporting the independent exploration of backcountry locales with a variety of models in multiple aircraft certification classes
• The Washington-based company announced plans for a public offering of its stock this summer, now pending imminent qualification by the SEC
• The public funding of the company will give CubCrafters capital that it plans to use to accelerate the pace of fulfilling customer orders and increasing its service capabilities for existing clients
• The Reg A filing announced in July with a $50 million target offering attracted $5 million in reservations within just the first 48 hours, building to over $20 million in reservations in the following weeks
• Analysts predict the light aircraft market will continue to grow at a CAGR of of 5.9 percent through 2030 to command sales of $11.9 billion

Best-in-class backcountry aircraft producer CubCrafters turned heads when the company announced in July that it will make a public offering to raise investment capital through the sale of preferred stock. Within the first 48 hours of its announcement, CubCrafters received $5 million in reservations for 1 million planned shares, which has grown beyond $20 million in reservations in the subsequent weeks as the company awaits qualification for its listing from the U.S. Securities and Exchange Commission (“SEC”). The reservations for the company’s shares have taken off, rising closer and closer to its initial goal for the public offering (https://ibn.fm/54T2Q). “As our company has grown, we’re the only company now doing four categories of airplanes. We’re doing Part 23 certified, experimental, builder-assist kits, as well as Light Sport,” President and CEO Patrick Horgan told the Aero-News Network in July at the Experimental Aircraft Association’s annual AirVenture event in Oshkosh, Wis. (https://ibn.fm/dmXTa). “Jim Richmond is the guy who started our business. … He initiated this idea, to grow our business through a public offering versus divesting it of a foreign source or another way,” Horgan said. “We’re innovating, we’re always working on new things. … And this will help us on the pace of those, which is what our customers want.” Vice President of Sales and Marketing Brad Damm underscored the company’s intention to use an infusion of funding to accelerate the rate of production by noting that CubCrafters was already sold out for all of this year and next year, as well as at least halfway through 2024 with the expectation that the company would soon be taking orders for 2025. “We’ve got to get that down and get airplanes to customers faster,” Damm said. “We are also targeting better service and better customer support. We’ve got a fleet of about 1,500 airplanes out there now (and) customers want, need and deserve that support.” CubCrafters’ legacy stands in reviving the classic Piper PA-18 Super Cub light aircraft design with a completely modern approach over the past 40-plus years. In August, the company rolled out a new lightweight engine for its Carbon Cub model that improves on the CC340 that made previously unheard-of short takeoff and landing (“STOL”) performance possible for backcountry enthusiasts. The new CC363i F/P is a higher displacement fuel-injected engine with more horsepower than the CC340, according to the company. Following the final phases of flight testing, CubCrafters is beginning to ship engine kits to customers this month (https://ibn.fm/fici5). The company has developed seven models that emphasize flexibility in options for backcountry exploration with landing gear configurations including nosewheel, tailwheel, floats, and skis. Damm said the market for backcountry exploration bush planes “has really exploded” as COVID-weary populations began seeking out options for fun, safe travel and self-determination, which is borne out by analysts’ forecasts that light and ultralight aircraft sales will hit $11.9 billion by 2030 (https://ibn.fm/6NEaW). For more information, visit the company’s website at www.CubCrafters.com. NOTE TO INVESTORS: The latest news and updates relating to CubCrafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

• Ketamine used for decades in large doses for surgical anesthesia, low-dose treatments currently prescribed for pain relief, sedation, and treatment-resistant depression
• Silo’s time-released ketamine formulation SP-26 currently undergoing safety evaluation, study to uncover maximum tolerated dosing data for future trials
• SP-26 previously reported positive results in reducing neuropathic nerve pain
• Silo preparing FDA Pre-Investigational New Drug (“IND”) package for SP-26, intends to pursue 505(b)(2) regulatory pathway

Ketamine was approved in the United States in 1970 and has been used extensively for surgical anesthesia. Since then, use of the drug in small doses has expanded considerably to treat pain and treatment-resistant depression (https://ibn.fm/2I6zY). Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on the use of traditional medicine and psychedelics as therapeutics, is currently developing ketamine treatments for fibromyalgia – a chronic disease that causes pain throughout the body. With no cure available, fibromyalgia can be a debilitating condition that extends beyond pain to cause extreme fatigue, anxiety, and memory issues. Silo’s novel ketamine formulation, designated as SP-26, is currently undergoing a safety evaluation to treat fibromyalgia (https://ibn.fm/URu60). “We are working closely with our joint venture partner Zylö Therapeutics in developing a topical sustained released ketamine utilizing Z-pod(TM) technology,” said Eric Weisblum, CEO of Silo Pharma. “Preclinical studies have already shown that our joint developed delivery method and formulation can hold and distribute ketamine in a time-released manner. SP-26 reported positive results in reducing neuropathic nerve pain. This safety evaluation study will uncover maximum tolerated dosing data that will inform our future trials.” Silo’s cooperation with Zylö Therapeutics provides a distinct competitive advantage for the formulation through the use of Zylö’s Z-pod(R) delivery system that provides treatment benefits while reducing hallucinogenic effects (https://ibn.fm/XXRME). With the ability to adapt to the characteristics of a specific compound, Z-pods(R) can be customized to target delivery, increase bioavailability, and improve stability. The company additionally announced collaboration with a regulatory partner to prepare an FDA Pre-Investigational New Drug (“IND”) package for SP-26 with the intention of pursuing a 505(b)(2) regulatory pathway for the drug candidate (https://ibn.fm/1rEia). “We are confident that our highly constructive pre-clinical work on SP-26 will offer strong support for our pre-IND package as we seek to advance our time-released ketamine delivery system into the clinic,” said Weisblum. “We intend to pursue the 505(b)(2) regulatory pathway and have engaged Premier Consulting as a true strategic partner to pave the way for productive discussions and alignment with the FDA.” Silo Pharma Inc. is fusing traditional therapeutics with psychedelic research to provide novel treatments for numerous indications, including post-traumatic stress disorder (“PTSD”), fibromyalgia, Alzheimer’s disease, and other rare neurological disorders. The company’s mission is to identify assets to license and fund research with leading universities for treatments the company believes will transform the healthcare industry and improve patient outcomes. For more information, visit the company’s website at www.SiloPharma.com. NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO